AbCellera Biologics Inc. (ABCL): 7 insider purchases in the last two years (3 opportunistic).
| Filed | Insider | Shares | Price | Value | Type |
|---|---|---|---|---|---|
| Mar 2, 2026 | Thermopylae Holdings Ltd. TenPercentOwner | 38,000 | $3.44 | $130.7K | opportunistic |
| Feb 27, 2026 | Booth Andrew Officer | 42,600 | $3.42 | $145.7K | no history |
| Feb 27, 2026 | Thermopylae Holdings Ltd. TenPercentOwner | 177,457 | $3.27 | $580.3K | opportunistic |
| Nov 26, 2025 | Montalbano John S. Director | 50,000 | $3.57 | $178.5K | no history |
| Mar 11, 2025 | Thermopylae Holdings Ltd. TenPercentOwner | 343,631 | $2.16 | $742.2K | opportunistic |
| Mar 10, 2025 | Montalbano John S. Director | 25,000 | $2.30 | $57.5K | no history |
| Mar 7, 2025 | Montalbano John S. Director | 60,000 | $2.34 | $140.4K | no history |
Open-market purchases from SEC Form 4. "Opportunistic" = this insider trades every year but not on a fixed schedule (Cohen, Malloy & Pomorski); "routine" buys carry little information.
Free account. Know when insiders, famous funds or Congress trade it.